Integral Molecular’s Chikungunya Neutralization Kit is the idea; starter kit for easy neutralization assays using replication-incompetent pseudoviruses. The kit includes Chikungunya Reporter Virus Particles (RVPs), a recombinant monoclonal antibody that neutralizes chikungunya, and RVPs bearing VSV-G as a negative control for neutralization by chikungunya-specific antibodies.
Catalog Number | Product | Unit |
RVP-1101G/L | Chikungunya Reporter Virus Particles | 2 vials (1 mL each) |
IM-CKV063 | Chikungunya neutralizing antibody | 1 vial (100 ug) |
RVP-1002G/L | VSV Reporter Virus Particles with MLV core | 1 vial (1 mL) |
Reporter Virus Particles (RVPs) are replication-incompetent pseudotyped virus particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation. Chikungunya (CHIKV) RVPs display chikungunya E2/E1 viral entry and fusion proteins on a heterologous virus core. They carry a modified genome that expresses an optical reporter gene (GFP or luciferase) within 24 hours of cellular infection.
IM-CKV063 is a recombinant monoclonal antibody that neutralizes chikungunya. The antibody sequence was recovered from an individual who was infected and recovered from CHIKV during the 2006 outbreak in La Réunion, France. The antibody epitope is well characterized and spans domain A and domain B of two neighboring E2 within one spike.
VSV RVPs function as a control for RVP experiments to differentiate specific versus non-specific effects on neutralization. VSV RVPs display VSV-G on a heterologous MLV core.
For tips on setting up your own neutralization assay, visit Pseudovirus Neutralization Assays: A How-to Guide for Getting Started. For more details about RVPs, their applications, and answers to frequently asked questions, visit the Reporter Virus Particle Information page.
Product | Neutralization Kit - Chikungunya Reporter Virus Particles, Antibody |
Catalog Number | KIT-1101 |
Strain | S27 |
Packaging | 20% FBS/DMEM |
Recommended Input Range | 2.5-20 uL per well (96-well plate) using the 293T-ACE2 stable cell line |
Lead time | Ready to ship |
Shipping | Shipped on dry ice |
Storage conditions | Store at -80°C (+/- 10°C) upon receipt |
Size | 4 total vials |
Warranty | Terms and Conditions (pdf) |
SDS | |
Protocols | |
Technical Data Sheets | CHIKV RVP Technical Data Sheets |
Integral Molecular’s products for chikungunya neutralization assays have been cited in leading publications describing both vaccine and therapeutic antibody development. Example publications include:
- Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis. Jin et al. 2015 Cell Rep. 13, 11
- Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy. Fong et al. 2014 J Virology 88, 24